CHGA
Chromogranin-A
Also known as: CMGA_HUMAN, PHE5, PHES
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P10645
- Gene
- CHGA
- Ensembl
- ENSG00000100604
- Chromosome
- 14
- Canonical length
- 457 aa
- Protein class
- Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Vesicles
- Secretome location
- Intracellular and membrane
OverviewNCBI Gene
The protein encoded by this gene is a member of the chromogranin/secretogranin family of neuroendocrine secretory proteins. It is found in secretory vesicles of neurons and endocrine cells. This gene product is a precursor to three biologically active peptides; vasostatin, pancreastatin, and parastatin. These peptides act as autocrine or paracrine negative modulators of the neuroendocrine system. Two other peptides, catestatin and chromofungin, have antimicrobial activity and antifungal activity, respectively. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Sep 2014]
Canonical amino-acid sequenceUniProt
457 residues, UniProt reviewed canonical sequence.
>P10645|CHGA
1 MRSAAVLALL LCAGQVTALP VNSPMNKGDT EVMKCIVEVI SDTLSKPSPM PVSQECFETL
61 RGDERILSIL RHQNLLKELQ DLALQGAKER AHQQKKHSGF EDELSEVLEN QSSQAELKEA
121 VEEPSSKDVM EKREDSKEAE KSGEATDGAR PQALPEPMQE SKAEGNNQAP GEEEEEEEEA
181 TNTHPPASLP SQKYPGPQAE GDSEGLSQGL VDREKGLSAE PGWQAKREEE EEEEEEAEAG
241 EEAVPEEEGP TVVLNPHPSL GYKEIRKGES RSEALAVDGA GKPGAEEAQD PEGKGEQEHS
301 QQKEEEEEMA VVPQGLFRGG KSGELEQEEE RLSKEWEDSK RWSKMDQLAK ELTAEKRLEG
361 QEEEEDNRDS SMKLSFRARA YGFRGPGPQL RRGWRPSSRE DSLEAGLPLQ VRGYPEEKKE
421 EEGSANRRPE DQELESLSAI EAELEKVAHQ LQALRRGLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CHGA can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.64
- Highest tissue expression
- 6,179 nTPM
Expression across tissuesHPA
Tissue
- parathyroid gland: 6,179 nTPM
- adrenal gland: 1,180 nTPM
- pituitary gland: 432 nTPM
- stomach: 391 nTPM
- cerebral cortex: 242 nTPM
- duodenum: 229 nTPM
Single-cell type
- neuroendocrine cells: 599 nCPM
- pancreatic islet cells: 112 nCPM
- gonadotrophs: 48 nCPM
- other brain neurons: 47 nCPM
- brain inhibitory neurons: 41 nCPM
- brain excitatory neurons: 29 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- cerebral cortex: 858 nTPM
- white matter: 400 nTPM
- medulla oblongata: 109 nTPM
- basal ganglia: 103 nTPM
- pons: 87 nTPM
- hypothalamus: 79 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about CHGA.
Disease | ImmuneIEDB
Conditions an epitope on CHGA was assayed in.
- type 1 diabetes mellitus T cell
ReferencesPubMed · IEDB
Publications for CHGA from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.
Reference: AutoantibodyPubMed
2 publications
- Circulating chromogranin A reveals extra-articular involvement in patients with rheumatoid arthritis and curbs TNF-alpha-elicited endothelial activation.
2009 · J Leukoc Biol · RCR 1.5 · 52 citations - Autoantibodies to chromogranin A are potential diagnostic biomarkers for non-small cell lung cancer.
2015 · Tumour Biol · RCR 0.4 · 11 citations
Reference: T cellIEDB
6 publications
- High-throughput determination of the antigen specificities of T cell receptors in single cells.
2018 · Nat Biotechnol · RCR 4.5 · 163 citations - Hybrid Insulin Peptides Are Autoantigens in Type 1 Diabetes.
2019 · Diabetes · RCR 2.8 · 75 citations - Novel T-Cell Reactivities to Hybrid Insulin Peptides in Islet Autoantibody-Positive At-Risk Individuals.
2025 · Diabetes · RCR 2.6 · 8 citations - The antigen presentation landscape of cytokine-stressed human pancreatic islets.
2025 · Cell Rep · RCR 2.5 · 8 citations - Chromogranin A is a T cell antigen in human type 1 diabetes.
2014 · J Autoimmun · RCR 2 · 68 citations
Show 1 more
- Identification of autoreactive CD8+ T cell responses targeting chromogranin A in humanized NOD mice and type 1 diabetes patients.
2015 · Clin Immunol · RCR 0.9 · 27 citations
Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. IEDB — curated epitope assays from the Immune Epitope Database (Vita et al., Nucleic Acids Research 2019). Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.57
- gnomAD pLI
- 0.03
- gnomAD missense Z
- 0.82
- DepMap mean gene effect
- 0.01
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 2% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- adenylate cyclase-activating adrenergic receptor signaling pathway
- defense response to bacterium
- defense response to fungus
- defense response to Gram-negative bacterium
- defense response to Gram-positive bacterium
- innate immune response
- killing of cells of another organism
- mast cell activation
- mast cell chemotaxis
- mast cell degranulation
- negative regulation of catecholamine secretion
- negative regulation of insulin secretion
- positive regulation of cardiac muscle contraction
- positive regulation of dense core granule biogenesis
- positive regulation of phospholipase C-activating G protein-coupled receptor signaling pathway
- positive regulation of relaxation of cardiac muscle
- protein localization to secretory granule
- regulation of blood pressure
- regulation of the force of heart contraction
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of CHGA in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CHGA as an antibody target. Whether an autoantibody or antibody against CHGA could matter depends on whether native CHGA is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CHGA is annotated as secreted, so native CHGA circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label CHGA as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...